EP 1513827 A1 20050316 - 1,3,5-TRIAZINE DERIVATIVES AS LIGANDS FOR HUMAN ADENOSINE-A3 RECEPTORS
Title (en)
1,3,5-TRIAZINE DERIVATIVES AS LIGANDS FOR HUMAN ADENOSINE-A3 RECEPTORS
Title (de)
1,3,5-TRIAZINDERIVATE ALS LIGANDEN FÜR HUMANE ADENOSIN-A3-REZEPTOREN
Title (fr)
DERIVES DE 1,3,5-TRIAZINE COMME LIGANDS POUR DES RECEPTEURS HUMAINS DE L'ADENOSINE A3
Publication
Application
Priority
- EP 03755982 A 20030528
- EP 0350203 W 20030528
- EP 02077310 A 20020530
Abstract (en)
[origin: WO03101980A1] The invention relates to a group of novel triazine derivatives which are ligands for human adenosine-A3 receptors, as well as to pharmaceutical compositions containing a pharmacologically active amount of at least one of these compounds as an active ingredient. The invention relates to compounds of the general formula (1) wherein Y represents a group of the general formula (A), (B) or (C) and all other symbols have the meanings as given in the description.
IPC 1-7
C07D 401/04; C07D 405/14; A61K 31/53; C07D 405/12; C07D 251/50; A61P 29/00
IPC 8 full level
A61K 31/53 (2006.01); A61K 31/5377 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 3/10 (2006.01); A61P 7/02 (2006.01); A61P 7/06 (2006.01); A61P 9/06 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 11/02 (2006.01); A61P 11/06 (2006.01); A61P 17/00 (2006.01); A61P 17/04 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); A61P 27/06 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 251/42 (2006.01); C07D 251/50 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 1/04 (2017.12); A61P 3/10 (2017.12); A61P 7/02 (2017.12); A61P 7/06 (2017.12); A61P 9/06 (2017.12); A61P 9/10 (2017.12); A61P 9/12 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 11/08 (2017.12); A61P 17/00 (2017.12); A61P 17/04 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 19/10 (2017.12); A61P 25/00 (2017.12); A61P 25/04 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 27/06 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 251/50 (2013.01); C07D 401/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01)
Citation (search report)
See references of WO 03101980A1
Citation (examination)
IAN SMITH ET AL: "A novel stable inhibitorof endopeptidase EC 3.4.24.15 and 3.4.24.16 potentiates bradykinin induced hypotension", Retrieved from the Internet <URL:http://www.springerlink.com/content/t74uu1w15276484k/>
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03101980 A1 20031211; AR 040231 A1 20050323; AU 2003250232 A1 20031219; AU 2003250232 B2 20080911; BR 0304925 A 20040928; CA 2484981 A1 20031211; CA 2484981 C 20110726; CN 1329388 C 20070801; CN 1646520 A 20050727; EP 1513827 A1 20050316; HK 1075045 A1 20051202; HR P20040970 A2 20050630; IL 164240 A0 20051218; IL 164240 A 20101230; JP 2005531600 A 20051020; JP 4590260 B2 20101201; MX PA04011948 A 20050331; PL 372418 A1 20050725; RU 2004138803 A 20050610; RU 2312859 C2 20071220; UA 77816 C2 20070115; ZA 200408029 B 20051006
DOCDB simple family (application)
EP 0350203 W 20030528; AR P030101920 A 20030530; AU 2003250232 A 20030528; BR 0304925 A 20030528; CA 2484981 A 20030528; CN 03809093 A 20030528; EP 03755982 A 20030528; HK 05107314 A 20050822; HR P20040970 A 20041015; IL 16424004 A 20040923; JP 2004509671 A 20030528; MX PA04011948 A 20030528; PL 37241803 A 20030528; RU 2004138803 A 20030528; UA 20041210642 A 20030528; ZA 200408029 A 20041005